Polymorphisms in the human paraoxonase (PON1) promoter

Ovid Technologies (Wolters Kluwer Health) - Tập 11 Số 1 - Trang 77-84 - 2001
Victoria H. Brophy1, Michele D. Hastings2, James B. Clendenning3, Rebecca J. Richter2, Gail P. Jarvik4,1, Clement E. Furlong2,1,5,6,7
1Medical Genetics, and
2Genetics,
3Biotechnology and Medicine, Divisions of
4Epidemiology
5e-mail:clem@u. washington.edu
6fax: +1 206 543 0754
7to Clement E. Furlong, Department of Genetics, Box 357360, University of Washington, Seattle, WA 98195–7360, USA Tel: +1 206 543 1193

Tóm tắt

Từ khóa


Tài liệu tham khảo

Aviram, 1998, J Clin Invest, 101, 1581, 10.1172/JCI1649

Blatter Garin, 1997, J Clin Invest, 99, 62, 10.1172/JCI119134

Brophy, 2000, Pharmacogenetics, 10, 453, 10.1097/00008571-200007000-00008

Clegg, 2000, Aids, 14, 103, 10.1097/00002030-200001280-00004

Clendenning, 1996, Genomics, 35, 586, 10.1006/geno.1996.0401

Davies, 1996, Nature Genet, 14, 334, 10.1038/ng1196-334

Farr, 1992, Nucleic Acids Res, 20, 920, 10.1093/nar/20.4.920

Feingold, 1998, Atherosclerosis, 139, 307, 10.1016/S0021-9150(98)00084-7

Furlong, 1989, Anal Biochem, 180, 242, 10.1016/0003-2697(89)90424-7

Furlong, 1998, Neurotoxicology, 19, 645

Graham, 1977, J Gen Virol, 36, 59, 10.1099/0022-1317-36-1-59

Green, 1995, Genomics, 25, 170, 10.1016/0888-7543(95)80123-4

Gronostajski, 1988, Nucleic Acids Res, 16, 2087, 10.1093/nar/16.5.2087

Hassett, 1991, Biochemistry, 30, 10141, 10.1021/bi00106a010

Heinemeyer, 1999, Nucleic Acids Res, 27, 318, 10.1093/nar/27.1.318

Higgins, 1992, CABIOS, 8, 189

Hoffman, 1987, Gene, 57, 267, 10.1016/0378-1119(87)90131-4

Humbert, 1993, Nature Genet, 3, 73, 10.1038/ng0193-73

James, 2000, Circulation, 101, 2252, 10.1161/01.CIR.101.19.2252

Jarvik, 2000, Arterioscler Thromb Vasc Biol, 20, 2441, 10.1161/01.ATV.20.11.2441

Knowles, 1980, Science, 209, 497, 10.1126/science.6248960

La Du, 1986, Ann Biol Clin, 44, 369

Leviev, 2000, Arterioscler Thromb Vasc Biol, 20, 516, 10.1161/01.ATV.20.2.516

Leviev, 1997, Arterioscler Thromb Vasc Biol, 17, 2935, 10.1161/01.ATV.17.11.2935

Li, 1993, J Toxicol Environ Health, 40, 337, 10.1080/15287399309531798

Li, 1995, Toxicol Lett, 76, 219, 10.1016/0378-4274(95)80006-Y

Li, 2000, Pharmacogenetics, 10, 767, 10.1097/00008571-200012000-00002

Mackness, 1987, Clin Chem, 33, 587, 10.1093/clinchem/33.4.587

Mackness, 1989, Clin Biochem, 22, 475, 10.1016/S0009-9120(89)80101-8

Mackness, 1991, Atherosclerosis, 86, 193, 10.1016/0021-9150(91)90215-O

Mackness, 1993, Atherosclerosis, 104, 129, 10.1016/0021-9150(93)90183-U

Mackness, 1997, Lancet, 349, 851, 10.1016/S0140-6736(05)61755-2

Mackness, 1998a, FEBS Lett, 423, 57, 10.1016/S0014-5793(98)00064-7

Mackness, 1998b, Atherosclerosis, 139, 341, 10.1016/S0021-9150(98)00095-1

Martin, 1998, Science, 282, 1907, 10.1126/science.282.5395.1907

Miller, 1988, Nucleic Acids Res, 16, 1215, 10.1093/nar/16.3.1215

Nagata, 1982, Proc Natl Acad Sci USA, 79, 6438, 10.1073/pnas.79.21.6438

Nishio, 1997, Biochem Biophys Res Commun, 236, 289, 10.1006/bbrc.1997.6961

Primo-Parmo, 1996, Genomics, 33, 498, 10.1006/geno.1996.0225

Quandt, 1995, Nucleic Acids Res, 23, 4878, 10.1093/nar/23.23.4878

Richter, 1999, Pharmacogenetics, 9, 745, 10.1097/00008571-199912000-00009

Santoro, 1988, Nature, 334, 218, 10.1038/334218a0

Shih, 1996, J Clin Invest, 97, 1630, 10.1172/JCI118589

Shih, 1998, Nature, 394, 284, 10.1038/28406

Suehiro, 2000, Atherosclerosis, 150, 295, 10.1016/S0021-9150(99)00379-2

Thompson, 1994, Nucleic Acids Res, 22, 4673, 10.1093/nar/22.22.4673

Watson, 1995, J Clin Invest, 96, 2882, 10.1172/JCI118359